SDD-formulated bardoxolone methyl shows promise in patients with diabetes and chronic kidney disease April 18, 2011
Niacin reduces phosphate levels in subjects with hyperphosphatemia due to hemodialysis April 18, 2011
Concert Pharmaceuticals begins phase I trial of chronic kidney disease treatment CTP-499 April 1, 2011
RSS